Amicus Therapeutics
FOLD
#3208
Rank
NZ$8.31 B
Marketcap
NZ$26.49
Share price
0.00%
Change (1 day)
98.01%
Change (1 year)

Market capitalization of Amicus Therapeutics (FOLD)

Last known market cap: NZ$8.31 Billion

As of November 2026 Amicus Therapeutics has a market cap of NZ$8.31 Billion. This makes Amicus Therapeutics the world's 3208th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Amicus Therapeutics from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$8.31 B9.29%
2025NZ$7.61 B49.16%
2024NZ$5.10 B-22.46%
2023NZ$6.57 B21.78%
2022NZ$5.40 B14.67%
2021NZ$4.71 B-43.5%
2020NZ$8.33 B125.75%
2019NZ$3.69 B36.57%
2018NZ$2.70 B-19.71%
2017NZ$3.36 B229.9%
2016NZ$1.02 B-42.37%
2015NZ$1.77 B74.63%
2014NZ$1.01 B472.52%
2013NZ$0.17 B9.61%
2012NZ$0.16 B5.86%
2011NZ$0.15 B-27.35%
2010NZ$0.21 B69.65%
2009NZ$0.12 B-59.47%
2008NZ$0.30 B-2.02%
2007NZ$0.31 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novo Nordisk
NVO
NZ$304.70 B 3,563.54%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
NZ$67.44 B 710.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$175.00 B 2,004.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
NZ$1.24 B-85.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$1.49 B-81.99%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$21.38 B 157.17%๐Ÿ‡บ๐Ÿ‡ธ USA